Association of the use of vitamin D receptor activators with incident cardiovascular disease and death after it in hemodialysis patients

Association of the use of vitamin D receptor activators with incident cardiovascular disease and death after it in hemodialysis patients - Association of the use of vitamin D receptor activators with incident cardiovascular disease and death after it in hemodialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011510

Enrollment

49659

Registered

2013-10-10

Start date

2011-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis patients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Prevalent hemodialysis patients at the end of 2004, 1) receiving thrice weekly hemodialysis 2) age between 20 and 90 years old 3) No previous history of myocardial infarction, cerebral infarction or cerebral bleeding

Exclusion criteria

Exclusion criteria: The subjects are excluded if any of the following data is unavailable; 1) the use/nonuse of VDRAs, age, sex, dialysis vintage, underlying kidney disease (diabetic or not), serum calcium, phosphate, intact PTH, albumin, CRP and body mass index at the end of 2004. 2) Information of past history of myocardial infarction, cerebral infarction or cerebral bleeding, and vital state (if dead, the cause of death) at the end of 2005.

Design outcomes

Primary

Measure	Time frame
1) Incident CVD (composite of myocardial infarction, cerebral infarction and cerebral bleeding) 2) Death after CVD	—

Countries

Japan

Contacts

Public ContactTetsuo Shoji

Osaka City University Graduate School of Medicine Department of Geriatrics and Vascular Medicine

t-shoji@med.osaka-cu.ac.jp06-6645-3930

Outcome results